Name (Synonyms) | Correlation | |
---|---|---|
drug2793 | covid-19 positive pregnant women Wiki | 1.00 |
drug387 | Blood test Wiki | 0.71 |
Name (Synonyms) | Correlation | |
---|---|---|
D019052 | Depression, Postpartum NIH | 0.45 |
D001008 | Anxiety Disorders NIH | 0.17 |
D003863 | Depression, NIH | 0.15 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
This study will perform prospective repeated serological antibody testing on a cohort of at least 1000 healthcare workers at Great Ormond Street Hospital. Within this cohort, a subset of 150-250 staff members with confirmed (PCR positive) SARS-CoV-2 disease will be followed with intensive monthly testing for 6 months to determine whether antibody levels in the blood are maintained or decrease during this time. All 1000 recruited healthcare workers will be followed 6-monthly
Description: To determine the kinetics (rate of change) of SARS-CoV-2 nucleo-capsid protein antibody titres in proven cases of SARS-CoV-2 over the 6 month period following infection
Measure: Change in serial monthly log-transformed antibody titre levels as measured Time: 6 months period post infectionDescription: To determine the proportion of completely asymptomatic healthcare workers who have evidence of SARS-CoV-2 antibodies in their serum indicative of past infection
Measure: Proportion of completely asymptomatic healthcare workers with evidence of SARS-CoV-2 antibodies Time: 12 monthsDescription: To determine the attack rate of SARS-CoV-2 in healthcare workers who have antibodies versus those who do not have antibodies
Measure: The attack rate of SARS-CoV-2 in healthcare workers who have antibodies compared to those who do not Time: Betwen 3 to 6 yearsDescription: To determine the immune correlates of protection (Antibody Titres sufficient for protection) against future exposure to SARS-CoV-2
Measure: The immune correlates of protection against future exposure to SARS-CoV-2 Time: Between 3 to 6 years